Larkö O
Department of Dermatology, University of Göteborg, Sahlgrenska Sjukhuset, Sweden.
Acta Derm Venereol. 1989;69(4):357-9.
Twenty-nine patients with psoriasis took part in a study which compared the therapeutic effect of Philips TL12 with a new narrow-band UVB lamp (Philips TL01). The patients were treated on an out-patient basis and treatment were given 3-5 times weekly for a maximum of 8 weeks. The study was conducted in a randomized left-right double-blind fashion. The total score on the TL01-side decreased rather more than on the TL12-side. Eleven patients preferred the TL01 lamp and one the TL12-side, whereas 17 patients had no preference. One of the drawbacks with the new lamp is that radiation times are almost doubled.
29名银屑病患者参与了一项研究,该研究比较了飞利浦TL12与一种新型窄谱中波紫外线灯(飞利浦TL01)的治疗效果。患者为门诊治疗,每周接受3至5次治疗,最长治疗8周。该研究采用随机左右双盲方式进行。TL01侧的总分下降幅度比TL12侧略大。11名患者更喜欢TL01灯,1名患者更喜欢TL12侧,而17名患者无偏好。这种新灯的缺点之一是照射时间几乎翻倍。